Transanal endoscopic microsurgery was associated with higher recurrence rate in both low- and high-risk T1 rectal cancer compared to surgical resection - Report - MDSpire

Transanal endoscopic microsurgery was associated with higher recurrence rate in both low- and high-risk T1 rectal cancer compared to surgical resection

  • By

  • Emelie Nilsson

  • Lisa Arvidsson

  • Carl-Fredrik Rönnow

  • Henrik Thorlacius

  • June 5, 2026

  • 0 min

Share

Clinical Report: TEM Shows Increased Recurrence Rates in T1 Rectal Cancer

Overview

Revise to specify the comparison basis for recurrence rates between TEM and traditional resection.

Background

Surgical resection has been the gold standard for treating pT1 rectal cancer, providing excellent oncological outcomes but with significant risks of complications. As early-stage rectal cancer diagnoses increase, the exploration of local resection techniques like TEM has gained interest due to their potential for fewer complications. However, concerns about higher local recurrence rates following TEM compared to traditional surgery necessitate further investigation.

Data Highlights

Remove placeholder text and provide relevant data or state explicitly that data is not available.

Key Findings

  • TEM is associated with higher local recurrence rates compared to surgical resection in T1 rectal cancer patients.
  • Current guidelines recommend completion surgical resection for high-risk tumors, while TEM may be considered for low-risk tumors.
  • Recurrence rates were evaluated across risk groups, highlighting the inadequacy of current risk classification in predicting outcomes.
  • Patients with adverse histopathological features after local excision may require additional treatment to mitigate recurrence risks.
  • The study utilized data from the Swedish Colorectal Cancer Registry, ensuring a comprehensive analysis of patient outcomes.

Clinical Implications

Clinicians should carefully evaluate the risks of local recurrence when considering TEM for T1 rectal cancer, especially in patients with high-risk features. Adherence to current guidelines regarding additional surgical interventions is crucial to optimize patient outcomes.

Conclusion

Reiterate the necessity for further research to validate findings and improve treatment protocols.

Related Resources & Content

  1. Surgical Endoscopy, 2026 -- Which prognostic factors for recurrence after transanal endoscopic microsurgery for early rectal cancer?
  2. Techniques in Coloproctology, 2023 -- Postoperative Surveillance in Oncology Following Transanal Total Mesorectal Excision for Rectal Tumors
  3. Surgical Endoscopy, 2022 -- Recurrence Risk Following Local Resection of T1 Rectal Cancer: A Meta-Analysis with Meta-Regression Insights
  4. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2025
  5. Comparative Analysis of Survival Outcomes: Transanal Total Mesorectal Excision (taTME) Versus Traditional Total Mesorectal Excision in a Propensity Score-Adjusted Retrospective Cohort Study
  6. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - PubMed
  7. Long-term outcomes of pT1 rectal cancer after transanal endoscopic surgery: again, a word of caution on high local recurrence — a cohort study - PMC
  8. Organ Preserving or Radical Surgery? A Systematic Review and Meta‐Analysis of Transanal Local Excision Versus Total Mesorectal Excision After Neoadjuvant Therapy for Rectal Cancer - AL Dhaheri - 2025 - Journal of Surgical Oncology - Wiley Online Library

Original Source(s)

Related Content